Related Experiment Video
Updated: May 4, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Virally targeted therapies for EBV-associated malignancies
Bruce F Israel1, Shannon C Kenney
1Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Novel therapies targeting Epstein-Barr virus (EBV)-positive lymphomas are being developed. These strategies aim to destroy EBV-infected cells by targeting the virus directly or enhancing the immune response.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Epstein-Barr virus (EBV) is implicated in specific lymphomas.
- EBV's genome is present in most tumor cells but few normal cells, presenting a therapeutic target.
Purpose of the Study:
- To review emerging therapeutic strategies targeting EBV-infected cells in lymphomas.
- To explore novel approaches for treating EBV-associated malignancies.
Main Methods:
- Review of current EBV-targeted therapy research and development.
- Analysis of strategies including viral oncogene inhibition, episome loss induction, and lytic cycle induction.
Main Results:
- Multiple EBV-targeted therapeutic strategies are under development.
- Approaches aim to selectively eliminate EBV-infected tumor cells.
Conclusions:
- EBV-targeted therapies offer a promising avenue for treating EBV-positive lymphomas.
- Enhancing host immune response against EBV antigens is a key strategy.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Inhibitors of Viral Protein Synthesis

